Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action

被引:44
|
作者
Oshaghi, Ebrahim Abbasi [1 ,2 ]
Goodarzi, Mohammad Taghi [1 ]
Higgins, Victoria [3 ]
Adeli, Khosrow [4 ]
机构
[1] Hamadan Univ Med Sci, Sch Med, Dept Clin Biochem, Hamadan, Iran
[2] Hamadan Univ Med Sci, Neurophysiol Res Ctr, Hamadan, Iran
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[4] Univ Toronto, Dept Biochem, Toronto, ON M5G 0A4, Canada
关键词
Diabetes; hyperglycemia; insulin resistance; resveratrol; natural product; TUMOR-NECROSIS-FACTOR; HIGH-FAT DIET; DENSITY LIPOPROTEIN OVERPRODUCTION; ACTIVATED PROTEIN-KINASE; CIRCULATING OXIDIZED LDL; TRIGLYCERIDE TRANSFER PROTEIN; CANCER CHEMOPREVENTIVE AGENT; ADIPOSE-TISSUE INFLAMMATION; MESSENGER-RNA TRANSLATION; BETA-CELL FUNCTION;
D O I
10.1080/10408363.2017.1343274
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Resveratrol (RES), a well-known antioxidant, is present in numerous plant species and, as a result, is easily obtained through dietary intake of plant-based foods and beverages. Several studies suggest that RES has anti-carcinogenic, anti-microbial, and anti-viral effects. It may also have beneficial metabolic properties that result in mitigation of insulin resistance (IR) and related metabolic abnormalities, including dyslipidemia, hyperglycemia, and hyperinsulinemia through regulation of gene expression or the activity of rate-limiting enzymes. A large body of evidence supports the beneficial effects of RES in the management and treatment of IR, type 2 diabetes, and related complications through a multitude of mechanisms. This review article focuses on the mechanisms of action of RES, the mechanisms leading to improved insulin sensitivity, and its clinical role in the management and treatment of type 2 diabetes.
引用
收藏
页码:267 / 293
页数:27
相关论文
共 50 条
  • [1] Modulators of insulin action and their role in insulin resistance
    Pirola, L
    Johnston, AM
    Van Obberghen, E
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (Suppl 3) : S61 - S64
  • [2] Modulators of insulin action and their role in insulin resistance
    L Pirola
    A M Johnston
    E Van Obberghen
    [J]. International Journal of Obesity, 2003, 27 : S61 - S64
  • [3] The role of resveratrol in diabetes and obesity associated with insulin resistance
    Hoca, Mustafa
    Becer, Eda
    Vatansever, Hafize Seda
    [J]. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2023, 129 (02) : 555 - 561
  • [4] MECHANISM OF INSULIN ACTION, ROLE OF IONS AND THE CYTOSKELETON
    ALHABORI, M
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1993, 25 (08): : 1087 - 1099
  • [5] ON THE MECHANISM OF ACTION OF PREDNISONE-INDUCED INSULIN RESISTANCE
    PERIN, PC
    OZZELLO, A
    LAROSA, M
    CASSADER, M
    PAGANO, G
    LENTI, G
    [J]. DIABETOLOGIA, 1982, 23 (02) : 160 - 160
  • [6] Advances in the role of resveratrol and its mechanism of action in common gynecological tumors
    Yang, Qian
    Meng, Dandan
    Zhang, Qingchen
    Wang, Jin
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] Mechanism of insulin resistance in obesity: a role of ATP
    Ye, Jianping
    [J]. FRONTIERS OF MEDICINE, 2021, 15 (03) : 372 - 382
  • [8] Mechanism of insulin resistance in obesity: a role of ATP
    Jianping Ye
    [J]. Frontiers of Medicine, 2021, 15 : 372 - 382
  • [9] Mechanism of insulin resistance in obesity: a role of ATP
    Jianping Ye
    [J]. Frontiers of Medicine., 2021, 15 (03) - 382
  • [10] Resveratrol and Related Compounds as Antioxidants With an Allosteric Mechanism of Action in Epigenetic Drug Targets
    Farghali, H.
    Canova, N. Kutinova
    Lekic, N.
    [J]. PHYSIOLOGICAL RESEARCH, 2013, 62 (01) : 1 - 13